Adenosine receptor occupancy suppresses chemoattractant-induced phospholipase D activity by diminishing membrane recruitment of small GTPases

被引:24
作者
Thibault, N
Harbour, D
Borgeat, P
Naccache, PH
Bourgoin, SG
机构
[1] CHUQ, Ctr Rech Rhumatol & Immunol, MRC, Grp Mol Mechanisms Inflammat, Ste Foy, PQ G1V 4G2, Canada
[2] Univ Laval, Dept Physiol, Quebec City, PQ, Canada
[3] Univ Laval, Dept Med, Quebec City, PQ G1K 7P4, Canada
关键词
D O I
10.1182/blood.V95.2.519
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Adenosine (Ado) is an important autocrine modulator of neutrophil functions. In this study, we determined the effects of endogenous Ado on fMet-Leu-Phe (fMLP)induced phospholipase D (PLD) activity in neutrophils. The removal of extracellular Ado by Ado deaminase (ADA) or the blockade of its action by the A2a receptor antagonists 8-(3-chlorostyryl) caffeine (CSC) or CGS15943 markedly increased fMLP-induced PLD activation. The concentration-dependent stimulatory effects of CSC and CGS15943 were abolished by a pretreatment of neutrophil suspension-swith ADA, In contrast, the selective A2a receptor agonist CGS21680 suppressed fMLP-induced PLD activation. Furthermore, inhibition by CGS21680 of fMLP-induced PLD activity was reversed by CSC or CGS15943, The removal of Ado by ADA or the blockade of its action by CSC or CGS15943, markedly increased the membrane recruitment of cytosolic protein kinase C alpha (PKC alpha), RhoA, and ADP-ribosylation factor (ARF) in response to fMLP, As shown for PLD activity, the stimulatory effect of Ado receptor antagonists on PLD cofactors translocation was abolished by a pretreatment of the cells with ADA, Moreover, the membrane trans-location of both PKCa, RhoA, and ARF in response to fMLP was attenuated by CGS21680 and this effect of the A2a receptor agonist was antagonized by CSC or CGS15943, These data demonstrate that Ado released by neutrophils in the extracellular milieu inhibits PLD activation by blocking membrane association of ARF, RhoA, and PKC alpha through Ado A2a receptor occupancy. (Blood, 2000;95:519-527) (C) 2000 by The American Society of Hematology.
引用
收藏
页码:519 / 527
页数:9
相关论文
共 65 条
[1]  
AGWU DE, 1991, J IMMUNOL, V146, P3895
[2]  
Bouma MG, 1997, J IMMUNOL, V158, P5400
[3]   INVOLVEMENT OF A PHOSPHOLIPASE-D IN THE MECHANISM OF ACTION OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF) - PRIMING OF HUMAN NEUTROPHILS INVITRO WITH GM-CSF IS ASSOCIATED WITH ACCUMULATION OF PHOSPHATIDIC-ACID AND DIRADYLGLYCEROL [J].
BOURGOIN, S ;
PLANTE, E ;
GAUDRY, M ;
NACCACHE, PH ;
BORGEAT, P ;
POUBELLE, PE .
JOURNAL OF EXPERIMENTAL MEDICINE, 1990, 172 (03) :767-777
[4]  
BOURGOIN S, 1992, CELL SIGNAL, V4, P487
[5]   Mammalian lipid phosphate phosphohydrolases [J].
Brindley, DN ;
Waggoner, DW .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (38) :24281-24284
[6]   ADP-RIBOSYLATION FACTOR, A SMALL GTP-DEPENDENT REGULATORY PROTEIN, STIMULATES PHOSPHOLIPASE-D ACTIVITY [J].
BROWN, HA ;
GUTOWSKI, S ;
MOOMAW, CR ;
SLAUGHTER, C ;
STERNWEIS, PC .
CELL, 1993, 75 (06) :1137-1144
[7]   Phospholipase D: Regulation by GTPases and protein kinase C and physiological relevance [J].
Cockcroft, S .
PROGRESS IN LIPID RESEARCH, 1996, 35 (04) :345-370
[8]   PHOSPHOLIPASE-D - A DOWNSTREAM EFFECTOR OF ARF IN GRANULOCYTES [J].
COCKCROFT, S ;
THOMAS, GMH ;
FENSOME, A ;
GENY, B ;
CUNNINGHAM, E ;
GOUT, I ;
HILES, I ;
TOTTY, NF ;
TRUONG, Q ;
HSUAN, JJ .
SCIENCE, 1994, 263 (5146) :523-526
[9]   Phospholipase D2, a distinct phospholipase D isoform with novel regulatory properties that provokes cytoskeletal reorganization [J].
Colley, WC ;
Sung, TC ;
Roll, R ;
Jenco, J ;
Hammond, SM ;
Altshuller, Y ;
BarSagi, D ;
Morris, AJ ;
Frohman, MA .
CURRENT BIOLOGY, 1997, 7 (03) :191-201
[10]  
COLLIS MG, 1993, TRENDS PHARMACOL SCI, V14, P360